Continuation versus discontinuation of antiplatelet therapy for bleeding and ischaemic events in adults undergoing non‐cardiac surgery
Referencias
Additional references
Berger PB, Kleiman NS, Pencina MJ, Hsieh WH, Steinhubl SR, Jeremias A, et al. Frequency of major noncardiac surgery and subsequent adverse events in the year after drug‐eluting stent placement: results from the EVENT (Evaluation of Drug‐Eluting Stents and Ischemic Events) Registry. Journal of the American College of Cardiology. Cardiovascular Interventions 2010;3(9):920‐7. [PUBMED: 20850090]
Covidence. www.covidence.org (accessed 24 May 2016).
Devereaux PJ, Eikelboom J. Insights into myocardial infarction after noncardiac surgery in patients with a prior coronary artery stent. British Journal of Anaesthesia 2016;116(5):584‐6. [PUBMED: 27106960]
Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta‐analysis detected by a simple, graphical test. BMJ (Clinical research ed.) 1997;315(7109):629‐34. [PUBMED: 9310563]
Thomson Reuters. Endnote X5. www.endnote.com, 2011 (accessed 2016).
Fleisher LA, Fleischmann KE, Auerbach AD, Barnason SA, Beckman JA, Bozkurt B, et al. 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2014;130(24):2215‐45. [PUBMED: 25085962]
Guyatt GH, Oxman AD, Kunz R, Vist GE, Falck‐Ytter Y, Schunemann HJ, et al. What is "quality of evidence" and why is it important to clinicians?. BMJ (Clinical research ed.) 2008;336(7651):995‐8. [PUBMED: 18456631]
Guyatt GH, Oxman AD, Kunz R, Woodcock J, Brozek J, Helfand M, et al. GRADE guidelines: 7. Rating the quality of evidence ‐ inconsistency. Journal of Clinical Epidemiology 2011;64(12):1294‐302. [PUBMED: 21803546]
Hawn MT, Graham LA, Richman JS, Itani KM, Henderson WG, Maddox TM. Risk of major adverse cardiac events following noncardiac surgery in patients with coronary stents. JAMA 2013;310(14):1462‐72. [PUBMED: 24101118]
Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. [updated March 2011]. The Cochrane Collaboration, 2011. www.cochrane‐handbook.org.
Keeling D, Campbell Tait R, Watson H. Peri‐operative management of anticoagulation and antiplatelet therapy. http://www.b‐s‐h.org.uk/guidelines/guidelines/peri‐operative‐management‐of‐anticoagulation‐and‐antiplatelet‐therapy/ (accessed 22 November 2016).
Korte W, Cattaneo M, Chassot PG, Eichinger S, von Heymann C, Hofmann N, et al. Peri‐operative management of antiplatelet therapy in patients with coronary artery disease: joint position paper by members of the Working Group on Perioperative Haemostasis of the Society on Thrombosis and Haemostasis Research (GTH), the Working Group on Perioperative Coagulation of the Austrian Society for Anesthesiology, Resuscitation and Intensive Care (OGARI) and the Working Group on Thrombosis of the European Society for Cardiology (ESC). Thrombosis and Haemostasis 2011;105(5):743‐9. [PUBMED: 21437351]
Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B, et al. 2015 ACC/AHA/SCAI focused update on primary percutaneous coronary intervention for patients with ST‐elevation myocardial infarction: an update of the 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention and the 2013 ACCF/AHA guideline for the management of ST‐elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines and the Society for Cardiovascular Angiography and Interventions. Circulation 2016;133(11):1135‐47. [PUBMED: 26490017]
Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta‐analyses of studies that evaluate health care interventions: explanation and elaboration. Journal of Clinical Epidemiology 2009;62(10):e1‐34. [PUBMED: 19631507]
Mantz J, Samama CM, Tubach F, Devereaux PJ, Collet JP, Albaladejo P, et al. Impact of preoperative maintenance or interruption of aspirin on thrombotic and bleeding events after elective non‐cardiac surgery: the multicentre, randomized, blinded, placebo‐controlled, STRATAGEM trial. British Journal of Anaesthesia 2011;107(6):899‐910. [PUBMED: 21873632]
National Institute for Health and Clinical Excellence (NICE). Clopidogrel and modified‐release dipyridamole for the prevention of occlusive vascular events. https://www.nice.org.uk/guidance/ta210;2010.
Oprea AD, Popescu WM. Perioperative management of antiplatelet therapy. British Journal of Anaesthesia 2013;111 Suppl 1:i3‐17. [PUBMED: 24335397]
Oscarsson A, Gupta A, Fredrikson M, Jarhult J, Nystrom M, Pettersson E, et al. To continue or discontinue aspirin in the perioperative period: a randomized, controlled clinical trial. British Journal of Anaesthesia 2010;104(3):305‐12. [PUBMED: 20150346]
The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
Rossini R, Musumeci G, Visconti LO, Bramucci E, Castiglioni B, De Servi S, et al. Perioperative management of antiplatelet therapy in patients with coronary stents undergoing cardiac and non‐cardiac surgery: a consensus document from Italian cardiological, surgical and anaesthesiological societies. EuroIntervention: journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 2014;10(1):38‐46. [PUBMED: 24832636]
Singla S, Sachdeva R, Uretsky BF. The risk of adverse cardiac and bleeding events following noncardiac surgery relative to antiplatelet therapy in patients with prior percutaneous coronary intervention. Journal of the American College of Cardiology 2012;60(20):2005‐16. [PUBMED: 23083781]
Sorensen R, Hansen ML, Abildstrom SZ, Hvelplund A, Andersson C, Jorgensen C, et al. Risk of bleeding in patients with acute myocardial infarction treated with different combinations of aspirin, clopidogrel, and vitamin K antagonists in Denmark: a retrospective analysis of nationwide registry data. Lancet (London, England) 2009;374(9706):1967‐74. [PUBMED: 20006130]
Wasowicz M, Syed S, Wijeysundera DN, Starzyk L, Grewal D, Ragoonanan T, et al. Effectiveness of platelet inhibition on major adverse cardiac events in non‐cardiac surgery after percutaneous coronary intervention: a prospective cohort study. British Journal of Anaesthesia 2016;116(4):493‐500. [PUBMED: 26888800]
Wijeysundera DN, Wijeysundera HC, Yun L, Wasowicz M, Beattie WS, Velianou JL, et al. Risk of elective major noncardiac surgery after coronary stent insertion: a population‐based study. Circulation 2012;126(11):1355‐62. [PUBMED: 22893606]
